AMH
8
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
11 treatments under study, led by Blood Sample
Research Leaders
11 sponsors active, led by Medical University of Vienna
Related Conditions
Often studied with 19 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (8)
Effect of Antimullerian Hormone Levels on the Inflammatory Index, Phytochemical Index and NRF Nutrient Density
In Vitro Maturation of Human Eggs
Hormones in Hypogonadotropic Hypogonadism
AMHR2 Polymorphism in Blood and Granulosa Cells in Unexplained Infertility
Predictive Value of New AMH Test Method for Ovarian Response
AMH and Pregnancy Outcome in IVF
Serum AMH Levels in Patients Who Underwent Hypogastric Artery Ligation
Ovarian Function and Reserve Parameters After Discontinuation of Long-term Use of Oral Contraception
Research Network
Common Treatments
- Blood Sample1
- Chemiluminescence1
- Hormone Profile1
- Pausing Oral Contraceptive1
- Amhr2 Polymorphism In Granulosa Cell1
Active Sponsors
- Medical University of Vienna1
- Bezmialem Vakif University1
- Al Baraka Fertility Hospital1
- Colorado Center for Reproductive Medicine1
- Reproductive & Genetic Hospital of CITIC-Xiangya1
Top Investigators
Ankara Etlik Zubeyde Hanım Women's Health Training and Research Hospital, Ankara, Turkey.
Kanuni Sultan Suleyman Training and Research Hospital
Medical University of Vienna
BEZMİALEM VAKIF ÜNİVERSİTESİ
Reproductive & Genetic Hospital of CITIC-Xiangya
Related Conditions
- Infertility Female2
- Ivf2
- Infertility2
- Polycystic Ovary Syndrome1
- Pcos1